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Abstract
Background: The incidence of breast cancer in Asia is increasing because of urbanization and lifestyle changes.
In the developing countries in Asia, women present at late stages, and mortality is high. Mammographic screening
is the only evidence-based screening modality that reduces breast cancer mortality. To date, only opportunistic
screening is offered in the majority of Asian countries because of the lack of justification and funding. Nevertheless,
there have been few reports on the effectiveness of such programmes. In this study, we describe the cancer
detection rate and challenges experienced in an opportunistic mammographic screening programme in Malaysia.
Methods: From October 2011 to June 2015, 1,778 asymptomatic women, aged 40–74 years, underwent subsidised
mammographic screening. All patients had a clinical breast examination before mammographic screening, and
women with mammographic abnormalities were referred to a surgeon. The cancer detection rate and variables
associated with a recommendation for adjunct ultrasonography were determined.
Results: The mean age for screening was 50.8 years and seven cancers (0.39%) were detected. The detection rate
was 0.64% in women aged 50 years and above, and 0.12% in women below 50 years old. Adjunct ultrasonography
was recommended in 30.7% of women, and was significantly associated with age, menopausal status, mammographic
density and radiologist’s experience. The main reasons cited for recommendation of an adjunct ultrasound was dense
breasts and mammographic abnormalities.
Discussion: The cancer detection rate is similar to population-based screening mammography programmes in
high-income Asian countries. Unlike population-based screening programmes in Caucasian populations where the
adjunct ultrasonography rate is 2–4%, we report that 3 out of 10 women attending screening mammography were
recommended for adjunct ultrasonography. This could be because Asian women attending screening are likely
premenopausal and hence have denser breasts. Radiologists who reported more than 360 mammograms were more
confident in reporting a mammogram as normal without adjunct ultrasonography compared to those who reported
less than 180 mammograms.
Conclusion: Our subsidised opportunistic mammographic screening programme is able to provide equivalent cancer
detection rates but the high recall for adjunct ultrasonography would make screening less cost-effective.
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Background
Breast cancer is the most common cancer amongst
women, both in developed and less developed countries. It
is a global disease burden, accounting for approximately
1.67 million out of 14.1 million new cancer cases reported
in 2012 [1]. Despite advancement and new discoveries that
have revolutionised the management of breast cancer, it
remains the leading cause of cancer-related deaths among
women. In low- and middle-income countries (LMICs),
incidence is lower than high-income countries, but has
been rising by as much as five percent annually [1]
because of the dramatic changes in social and lifestyle
determinants, including changes in reproductive factors,
environmental exposures, diet and exercise [2].
Although early detection of cancer improves survival,
breast cancer screening remains controversial [3]. Mam-
mographic screening has been well studied in high-income
countries (HICs), especially among Caucasians and is
shown to significantly reduce mortality. In most Western
countries, population-based screening programmes are
available with defined screening intervals and target popu-
lations [4]. By contrast, population-based screening is only
available in four Asian countries, namely Japan, Korea,
Singapore and Taiwan [5]. This is largely due to inadequate
resources in other Asian countries to carry out national
mammography programmes and lack of evidence on cost-
effectiveness [6].
Breast cancer is the most common cancer in Malaysia,
accounting for 18% of all cancers and 31% of cancers in
women. Compared to women of European descent
where the incidence peaks at 60–70 years [7], approxi-
mately half of the breast cancers detected in Malaysia
were younger than 50 [8]. Notably, there is limited data
on mammographic screening amongst younger women
(40–49 years) particularly Asian women [9], and there-
fore, the age to initiate such screening among Malaysian
women still remains controversial.
In Malaysia, like in the majority of Asian countries, a
population-based mammographic screening programme
is not feasible or cost-effective mainly because of the
lower incidence and lack of resources. Breast cancer in-
cidence in Malaysia is estimated to be 38.7 per 100,000
women, comparatively lower than Singapore (65.7 per
100,00) and higher income countries like the United
Kingdom (95 per 100,000) [1]. Opportunistic mammo-
graphic screening in Malaysia is provided by both gov-
ernmental agencies and non-governmental organisations
(NGOs). However, there has been little information on
the performance of such programmes, in terms of clin-
ical follow-up and cancer detection rate.
The objective of this study is to describe the challenges
encountered and to determine the cancer detection rate
and adjunct ultrasonography recommendation rate of an
opportunistic mammographic screening programme.
Methods
Recruitment
The Malaysian Mammography (MyMammo) study is a
subsidised, opportunistic mammographic screening pro-
gramme among Malaysian women aged 40 to 74 years in a
private tertiary hospital that serves a suburban locality in
Selangor, Malaysia. Selangor is home to 6.3 million people,
13% of which are women aged 40 to 74 years [10]. Screen-
ing was offered to women with no personal history of
breast cancer who have not had a mammogram recently
(at least a year prior to enrolment in the programme). Par-
ticipants were recruited through flyers, posters and media.
Written informed consent was obtained from all partici-
pants. Participants donated blood samples for research and
completed a questionnaire (Additional file 1) that included
demographic information, anthropometric data, menstrual
and reproductive history, family history of cancer, and mo-
tivators and barriers for participating in the MyMammo
Study.
From October 2011 to June 2015, a total of 1,966 sub-
jects participated in the programme. Of these, 35 women
have incomplete data and 153 women were symptom-
atic, leaving 1,778 women for analysis. All women had a
clinical breast examination by a medical officer and were
referred to a surgeon if there were any mammographic
abnormalities requiring further assessment. Women
with inconclusive and suspicious mammography reports
(BIRADS categories 0, 3, 4, or 5) were called for further
consultation and clinical examination with the surgeon.
The reporting radiologists were radiologists without fel-
lowship training in breast imaging.
The study protocol was developed in accordance with
the principles of the Declaration of Helsinki and ap-
proved by the Sime Darby Medical Centre Independent
Ethics Committee [201109.4].
Mammographic screening and mammographic density
measurements
Full Film Digital Mammography (FFDM) was performed
using the Hologic Selenia system, with two views
(mediolateral oblique and craniocaudal) for bilateral
breasts. Mammograms were reported by trained radiolo-
gists. The recommendation and reasons for adjunct ultra-
sonography were stated in the mammography report. The
findings were classified into 6 categories, based on the
Breast Imaging Reporting and Data System (BIRADS) by
the American College of Radiology (ACR).
The Volpara method was used to obtain volumetric
mammographic density measurements, and was previ-
ously described [11]. In short, the Volpara software
defines dense volume (cm3) as the integration of dense
thickness at each pixel, across all pixels of the mammo-
gram. Total breast volume (cm3) was calculated as a func-
tion of breast area and breast thickness. Percent dense
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volume (%) is the ratio of dense volume to total breast vol-
ume. The average percent dense volume of bilateral
breasts in CC view was used as the measurement of breast
density in this analysis.
Statistical analysis
Descriptive statistics were used to describe the demo-
graphics of the cohort, as well as to describe the recall rate
for adjunct ultrasonography and cancer detection rate of
the mammographic screening programme. Univariate
analyses, including independent-sample T-tests for con-
tinuous variables and chi-square tests of homogeneity for
categorical variables, were used to determine factors asso-
ciated with the recommendation for adjunct ultrasonog-
raphy. As the sensitivity of mammography is dependent
on mammographic density, it was incorporated into the
analysis. Other factors that were included were age, meno-
pausal status and parity as these factors are closely associ-
ated with breast density [12–14]. Logistic regression
models were used to evaluate the effect of multiple
variables on the recommendations for adjunct ultrasonog-
raphy. Statistical tests were two-sided, and a p-value less
than 0.05 was considered statistically significant. All
statistical analyses were performed using IBM Statistical
Package for Social Sciences (SPSS) version 23.0.
Results
Between October 2011 and June 2015, a total of 1,778
asymptomatic women aged 40–74 years underwent sub-
sidised mammographic screening. The majority of the
participants were Chinese (65.4%), followed by Indians
(16.5%), Malays (13.7%), and mixed or other ethnicities.
Notably, Chinese women were more likely to attend
screening and the demographics attending screening
were different from that of the overall population where
24.6% of the population are Chinese, 7.3% are Indians,
and 67.3% are Malays. Most of the women were well
educated and from a relatively high socio-economic
background. Ninety-three percent had at least secondary
education, and 51.2% with a monthly household income
of more than USD 1,200 (Table 1).
Cancer detection
Most (86.8%) of the screening mammograms were re-
ported as BIRADS 1 and 2 (normal or benign findings),
with 9.7% BIRADS 3 and 2.1% BIRADS 4 and 5
(suspicious or highly suggestive of malignancy).
Overall, Seven cancers or 0.39% [95% confidence inter-
val: 0.10%, 0.68%] were detected. Six cancers were de-
tected in women aged 50 and above with a cancer
detection rate of 0.64% [0.13%, 1.15%]. Only one cancer
was detected among women below 50, a detection rate
of 0.12% [0%, 0.35%]. Of the seven cancers detected, one




Age at enrolment (years) 40–74 50.75 (7.31)







Primary or less 123 6.9
Secondary 883 49.7
Tertiary 771 43.4
Missing data 1 0.1
Average monthly income (RM)




≥ 10,000 [≥ USD 2,300] 359 20.2
Missing data 58 3.3
Hormonal
Age at menarche (years)
< 12 220 12.4
12–13 1031 58.0
≥ 14 514 28.9









≥ 5 268 15.1
Unknown or data missing 2 0.1
Age at first birth (years)
< 20 63 3.5
20–24 340 19.1
25–29 678 38.1
≥ 30 452 25.4
Nulliparous 237 13.3
Unknown or missing data 8 0.4
Family history of breast
cancer (1° relative)
260 14.6
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was ductal carcinoma in situ (Stage 0), three were Stage
1 and three were Stage 2.
Adjunct ultrasonography
Recommendation for adjunct ultrasonography was made
in 30.7% [28.6%, 32.8%] of women. The most common
reason for recommendation was for regular nodularities
and opacities, 41.2% [37.1%, 45.3%]. However, dense
breasts alone accounted 20% [16.6%, 23.4%] of the
recommendation for ultrasonography. Other reasons
were for abnormalities such as breast asymmetry or
micro-calcifications (Table 2).
Factors affecting recommendation for adjunct ultra-
sonography were studied. Univariable analysis showed
that younger women, premenopausal women and
women with denser breasts were more likely to be rec-
ommended for adjunct ultrasonography. Radiologists
who reported more than 360 mammograms (of the total
of 1778 mammograms) were less likely to recommend
adjunct ultrasonography compared to those who recom-
mend less than 180 mammograms (Table 3). In multi-
variable analyses, only the interpretation volume by the
radiologists remained significantly associated with ultra-
sonography recommendation (Table 4).
Discussion
Our study of a subsidised opportunistic mammographic
screening programme shows that this programme is able
to provide equivalent cancer detection rates compared
to population-based screening programmes. However,
the low rate of cancer detection in women below 50
years and high recall rates for an adjunct
Table 2 Reasons for adjunct ultrasonography recommendation




Regular nodularities or opacities 225 41.2








Macro-calcifications (indeterminate) 65 11.9
Non-clustered micro-calcifications 48 8.8




Spiculated/suspicious masses 5 0.9
History of breast lumps/cysts 5 0.9
Benign-looking masses 4 0.7
Family history of breast cancer 4 0.7
Table 3 Univariate analysis of variables associated with adjunct
ultrasonography recommendation
Demographics Adjuvant ultrasonography recommendation





Age at enrolment (years)
< 50 301 (55.1%) 545 (44.2%) 0.000*
≥ 50 245 (44.9%) 687 (55.8%)
Mean age (SD) 49.93 (7.2) 51.12 (7.3) 0.002*
Body-mass index
(kg/m2), mean (SD)
24.72 (4.8) 25.07 (4.3) 0.129
Ethinicity
Chinese 360 (65.9%) 803 (65.2%) 0.719
Indian 95 (17.4%) 198 (16.1%)
Malay 69 (12.6%) 175 (14.2%)
Others 22 (4.0%) 56 (4.5%)
Hormonal
Age at menarche (years)
< 12 76 (14.0%) 144 (11.8%) 0.082
12–13 295 (54.5%) 736 (60.1%)
≥ 14 170 (31.4%) 344 (28.1%)
Menopausal status
Pre-/Peri-menopausal 320 (58.6%) 600 (48.7%) 0.001*
Post-menopausal 226 (41.4%) 631 (51.3%)
Number of pregnancies
0 78 (14.3%) 159 (12.9%) 0.094
1–2 180 (33.0%) 354 (28.8%)
3–4 203 (37.2%) 534 (43.3%)
≥ 5 85 (15.6%) 183 (14.9%)
Age at first birth (years)
< 20 23 (4.9%) 40 (3.7%) 0.021*
20–24 89 (19.1%) 251 (23.5%)
25–29 195 (41.8%) 483 (45.3%)
≥ 30 159 (34.1%) 293 (27.5%)
Parity
Parous 466 (85.3%) 1,067 (86.6%) 0.477
Non-parous 80 (14.7%) 165 (13.4%)
Average volume
density, (%)




242 (44.3%) 176 (14.3%) 0.000*
Radiologist reporting >
360 mammograms
304 (55.7%) 1,056 (85.7%)
*Statistically significant (p-value < 0.05)
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ultrasonography would not make it cost-effective to
screen women aged below 50.
The cancer detection rate of 0.39% demonstrated in
this study is similar to the screening programmes in
other Asian countries with similar incidence rates of
breast cancer, 0.48% in Singapore [15] and 0.5% in Hong
Kong [16]. It is also similar to a previous study on op-
portunistic mammographic screening in Malaysia, show-
ing a cancer detection rate of 0.5% [17]. In contrast, the
breast cancer detection rate in a high-income country,
such as Switzerland, with a higher incidence rate of
breast cancer was reported to be between 0.61% and
0.79% at the initial screen [18]. Notably, we report a low
cancer detection rate of 0.12% in women below 50 years
old, which is comparable to a similar study in Malaysia
which reported 0.2% [17]. In contrast, a Japanese study
showed a higher detection rate of 0.56% in women youn-
ger than 50 years, compared to 0.26% among women
aged 50 and above [19]. Taken together, as the cancer
detection rate is relatively low in this region, it may not
be cost-effective to conduct a population-based mam-
mographic screening programme [20].
Unlike population-based biennial screening pro-
grammes in Caucasian population where the adjunct
ultrasonography rate is 2 to 4%, our study showed that 3
out of 10 women attending screening mammography
were recommended for adjunct ultrasonography, which
would correspond to a recall rate of 30% for additional
procedures. International guidelines such the European
guidelines recommend that less than 7% should be
recalled for further assessment [4], as this would corres-
pond to a sensitivity of 83.3%, which is considered an
optimal trade-off between the benefit of finding add-
itional cancers and the increased number of procedures
for non-cancers and the associated anxieties experienced
by women [21].
We report that one possible reason for the high recall
rate is that in LMICs, there is a shortage of radiologists
trained in breast radiology. As shown in this study, the
higher the interpretation volume, the lower the recall
rates for adjunct ultrasonography. Several studies have
highlighted that recall rate is dependent on patient
population, radiologists and systemic factors [21–23].
Radiologists who are less experienced in breast imaging
lack confidence in passing a mammogram as normal
[24]. The study by the Breast Cancer Surveillance
Consortium (BCSC) group investigating the radiologists’
characteristics associated with interpretive performance
in screening mammography in the United States con-
cluded that fellowship training in breast imaging was the
only characteristic significantly associated with improved
sensitivity [25]. Of note, mammography is the only
evidence-based screening modality for breast cancer and
thus, much effort should be focused on maintaining and
achieving high quality mammograms. More training
courses to help radiologists continuously improve stan-
dards of practice and linking education programmes to
individual radiologist’s performance could potentially re-
duce recall rate [26–30].
Another reason for the high recall rate is that the Asian
women in our study may have mammographically denser
breasts. They were more likely to be pre-menopausal, Asian
women with lower BMI, which are all factors associated
with denser breasts. A previous study in Malaysia showed a
recall rate of 31.7% for ultrasonography, and was signifi-
cantly higher among the younger cohort [17]. In our study,
20% of women were recommended for ultrasound for
dense breasts alone, without any other abnormalities. Stud-
ies have demonstrated that Asian women have denser
breasts compared to Caucasian women [31, 32].
Our subsided mammographic screening programme
encountered several challenges. Compliance proved to
be a challenge as around 11% of the women did not return
to collect their mammogram reports. A third of the
women had to be contacted several times especially when
they were reported to have BIRADS 4 or BIRADS 5, re-
quiring further assessment. Even when contacted, about
10% were reluctant to have further investigations, as they
did not report any lumps. This clearly reflects the pivotal
role of pre-screening counselling in enabling and ensuring
that women understand the purpose and implications
of mammography and the significance of follow-up.







Age at enrolment (years)
< 50 1.828 (1.275, 2.620) 0.001*
50 and above 1.00 (ref.)
Body-mass index (kg/m2) 0.991 (0.952, 1.033) 0.678
Age at first birth (years)
< 20 1.00 (ref.)
20–24 0.497 (0.116, 2.128) 0.346
25–29 0.597 (0.148, 2.414) 0.469
≥ 30 0.703 (0.172, 2.880) 0.624
Volumetric Mammographic Density Measurement
Average % volume density (Volpara) 1.017 (0.992, 1.041) 0.186
Radiologists
Radiologist reporting < 180
mammograms
1.00 (ref.) 0.000*
Radiologist reporting > 360
mammograms
0.127 (0.089, 0.180)
*Statistically significant (p-value < 0.05)
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Compliance was highlighted as a challenge in an early
detection programme by clinical breast examination in the
Philippines where 42.4% of the women who were found to
have a breast lump refused further investigations [33].
As the programme was conducted in a private centre
and the majority of the women were not insured, many
were referred to public hospitals for further investigations
due to financial reasons. Although seven cancers were de-
tected, we acknowledge the possibility of missing some
cancers. The lack of an effective national cancer registry
also hampered the process of tracing and identifying can-
cers that were missed or developed later. However since
the cancer detection rate was similar to another opportun-
istic mammography screening programme conducted in a
public hospital, we presume that there are very few, if any,
missed cancers.
It is crucial to note than one out of the seven cancers
detected refused any cancer treatment, opting for alter-
native therapy. Such phenomenon was also seen in
Indonesia, in an early detection programme utilizing
screening mammography and clinical breast examin-
ation, in which only 42.8% of the women diagnosed with
breast cancer returned for treatment [34]. Hence, as well
as identifying the challenges to screening, identifying
barriers to treatment is essential to the success of any
early cancer detection programme.
Conclusion
A subsidised opportunistic mammographic screening
programme funded by an NGO is able to provide
equivalent cancer detection rates compared to other pro-
grammes reported in the region. The low detection rate in
women below 50 years coupled with the high recall rates
for an adjunct ultrasonography would not make it cost-
effective to screen women aged below 50. To reduce the
recall for an adjunct breast ultrasonography, it is impera-
tive to have comprehensive and continuous training mod-
ules for radiologists, especially those without fellowship
training in breast imaging. Undeniably, counselling plays a
pivotal role in patient’s awareness, voluntary compliance
and in improving patient care as a whole. Women should
be counselled about the benefits and drawbacks of mam-
mography screening, and the need for follow-up assess-
ments for any suspicious findings. An early detection
programme, such as this one, will have benefit in raising
breast awareness among women.
Additional file
Additional file 1: Mammogram Questionnaire. Malaysian 1000
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